Medicinal Cannabis Matters | Friday roundup 4th April 2025
Welcome back to Medicinal Cannabis Matters, your weekly dose of news, insights and breakthroughs in the medicinal cannabis sector. This week’s roundup includes UK council-led advocacy, global research in mental health and marking World Autism Awareness Day with an exploration of cannabis as a potential alternative treatment for adults with ASD (Autism Spectrum Disorder) and ADHD.
Exploring Alternatives | Cannabis & Neurodiversity
April 2nd marked World Autism Awareness Day. A time not just to recognise the spectrum of experiences within the neurodiverse community, but to examine how care options are evolving. For some adults with ADHD and ASD (Autism Spectrum Disorder), traditional treatments don’t always align with their needs or comfort levels. An increasing number are exploring medicinal cannabis as a therapeutic option – not as a last resort, but as a considered, conscious choice. From easing sensory sensitivity to supporting emotional balance, patient stories are beginning to shape a more nuanced conversation around cannabis and neurodiversity.
Welsh Council Moves to Protect Medical Cannabis Patients
Flintshire could soon become the first council in Wales to formally protect the rights of medicinal cannabis users. A motion set to go before council proposes that legally prescribed cannabis patients – including social housing tenants and council staff – receive added protections against discrimination. The policy would require cannabis patients to be considered in equality impact assessments, while also improving internal training and awareness around current legislation. Backed by personal stories like that of David Case, who uses prescribed cannabis to manage rheumatoid arthritis, the motion reflects growing calls for local authorities to recognise the legitimacy and challenges faced by patients.
Long-Term Benefits Backed by Data: Medicinal Cannabis & Quality of Life
A new 12 month observational study out of Australia, published this week, links medicinal cannabis use with sustained improvements in patients’ quality of life. Over 2,300 participants reported reductions in anxiety, depression, fatigue and sleep issues – adding to the growing body of evidence that supports cannabis as a long-term treatment for chronic conditions. The results are encouraging, particularly as healthcare systems seek effective alternatives to traditional pharmaceuticals with fewer side effects.
Swiss Research Links Legal Cannabis Access to Improved Mental Health
Could access to regulated cannabis make a difference in mental health outcomes? A recent Swiss study says yes. Researchers compared individuals enrolled in legal pilot access schemes to those still relying on unregulated sources – and found the former group reported significantly fewer symptoms of anxiety, depression and stress. As more countries explore legalisation frameworks, studies like this offer a clearer picture of the real-world benefits that come from safe, structured access to cannabis-based products.
If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey, Guernsey and the Isle of Man. Check your eligibility today.
https://www.medicann.co.uk/book-consultation/eligibility/
Disclaimer: This content is for informational purposes only and does not constitute medical advice. Please consult a healthcare professional for personalised medical guidance.
